Jonae R. Barnes
Contacto de Relaciones con Inversores en ATEA PHARMACEUTICALS, INC. .
Cargos activos de Jonae R. Barnes
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | 19/01/2021 | - |
| Public Communications Contact | 19/01/2021 | - |
Historial de carrera de Jonae R. Barnes
Antiguos cargos conocidos de Jonae R. Barnes.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Contacto de Relaciones con Inversores | 01/01/2007 | 01/12/2009 |
| Public Communications Contact | 01/01/2007 | 01/12/2009 | |
| POXEL | Contacto de Relaciones con Inversores | 14/03/2016 | - |
| Public Communications Contact | 14/03/2016 | - | |
| AGENUS INC. | Contacto de Relaciones con Inversores | 01/01/2011 | - |
| IDENIX PHARMACEUTICALS INC | Contacto de Relaciones con Inversores | - | - |
| Public Communications Contact | 29/10/2010 | - |
Formación de Jonae R. Barnes.
| Suffolk University | Undergraduate Degree |
| Boston University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Israel | 2 |
| Francia | 2 |
Operativa
| Investor Relations Contact | 5 |
| Public Communications Contact | 4 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AGENUS INC. | Health Technology |
| POXEL | Health Technology |
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jonae R. Barnes
- Experiencia